Peacock Karen 4

What Happened
Karen Peacock, a director of IDEXX Laboratories (IDXX), was granted equity awards on May 12, 2026: an option covering 525 shares and 234 deferred stock units (DSUs), for a combined 759 share-equivalents. Both grants are reported as derivative awards at $0.00 per share (no cash paid at grant).

Key Details

• Transaction date: 2026-05-12; Filing date: 2026-05-14 (timely filing).
• Reported awards: 525-share option (derivative) and 234 DSUs (derivative). Reported price: $0.00.
• Shares owned after transaction: not specified in the provided filing summary.
• Footnotes:
  • F1 — The option vests in one installment on the one-year anniversary of the grant or at the 2027 annual meeting, whichever is earlier.
  • F2 — Each DSU represents a contingent right to one share; DSUs vest on the same schedule as the option and are by default payable in common stock after a director’s resignation.
• Transaction code: A = Award/Grant.

Context
These awards are director compensation (not an open-market purchase or sale). The option gives the right to buy shares after vesting; DSUs are a deferred equity payment that converts to shares per the plan terms. Such grants are routine for board members and do not, by themselves, indicate a personal cash investment or an immediate change in market exposure.